First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

“ 401 (k) administrators also have an obligation to regularly review the funds they’re offering in the plan, so if any funds ...

Hims & Hers Health, Inc. (HIMS) shares rallied 5.7% in the last trading session to close at $34.75. This move can be attributable to notable volume with a higher number of shares being traded than in ...

Me shares are headed toward zero as the DNA testing company prepares to go bankrupt. The CEO wants to remain in control of ...

A woman says that her husband recently told her he no longer wants a romantic relationship with her, but would still like to ...

The comment from U.S. Commerce Secretary Howard Lutnick came a week after President Donald Trump turned the White House lawn ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Move Not Related to Weight-Loss Drug Market Headwind Importantly, the closure of Apostrophe is unrelated to the recent headwinds in the weight-loss drug market, which has caused Hims & Hers stock ...

The stock is up more than 40% since the beginning of the year, peaking in mid-February after Hims & Hers ran a controversial commercial about its weight-loss platform during the Super Bowl and ...